[Featured Stock] Osangjaiel Rises on Surging Demand for COVID-19 Self-Diagnosis Kits Amid Rebound

OsangJaiel is showing strong performance. It is interpreted that this is influenced by news that demand for self-diagnostic kits is rapidly increasing as COVID-19 shows signs of resurgence.

As of 1:59 PM on the 7th, OsangJaiel is trading at 4,135 KRW, up 8.1% compared to the previous day.

According to the Korea Disease Control and Prevention Agency, a survey conducted on 220 sample surveillance institutions at hospital level with more than 200 beds nationwide revealed that the number of COVID-19 inpatients increased fivefold from 91 in the first week of last month to 464 in the last week. The number of COVID-19 patients has recently turned to an upward trend along with the spread of the Omicron variant.

Accordingly, CU reported that sales of self-diagnostic kits increased by 132% compared to the previous month last month. From the 1st to the 5th of this month, sales surged by 833% compared to the previous month. Looking at the sales growth rate by region last month, Jeju recorded the highest at 316.4%, followed by Jeonnam at 246.9%, Busan at 236.1%, Gyeongnam at 198.4%, and Ulsan at 186.7%.

Meanwhile, OsangJaiel’s subsidiary, Osang Healthcare, has received domestic sales approval from the Ministry of Food and Drug Safety for its COVID-19 self-diagnostic kits.

This content was produced with the assistance of AI translation services.